Official UK procurement notice
Insulin Pumps, Continuous Glucose Monitoring, Closed Loop Insulin Delivery Systems and
Authority: NHS Supply Chain Operated by DHL Supply Chain Limited acting as agent of Supply Chain Coordination Ltd (SCCL) (NHS & healthcare)·Consortium: 2 public authorities
What is being bought6 lots · detail below
Published requirement descriptionIn January 2022 NHS Supply Chain launched a non-exclusive Framework Agreement for supply to NHS Supply Chain customer base of Insulin Pumps Continuous Glucose Monitoring Closed Loop Insulin Delivery Systems and Associated Products.
The Framework Agreement provides one ordering platform for all technologies, the objective to award broadly across the Framework Agreement to ensure continuity of supply for all key product areas and to also allow optimisation opportunities to be identified. In accordance with Section 3 of the ITT that was published in 2021, NHS Supply Chain has taken the decision to open the Framework Agreement to new Applicants to ensure the Framework Agreement continues to offer the broadest possible range of products to the NHS, as well as ensuring any new technologies and innovations in this product area are made available via the Framework Agreement.
Applicants successfully awarded to the Framework Agreement during this Agile Tender will be awarded with the incumbent suppliers who were awarded to the Framework Agreement following the previous tendering exercise (Contract Award Notice reference: 2022/S 000-000260 which can be viewed at: www.gov.uk/find-tender).This ↗ agreement is for the supply of Insulin Pumps, Continuous Glucose Monitoring (CGM) devices, Applications or software to enable the function of Closed Loop Insulin Delivery Systems and also for the dedicated consumables and accessories for the products listed above.
The Framework Agreement was launched in January 2022 with an initial term of 24 months with an option to extend incrementally for up to a total period of 48 months. Applicants successfully awarded to the Framework Agreement during this Agile Tender will therefore be awarded for an initial period of 12 months, with an option to extend incrementally for up to a total period of 36 months.
It is anticipated that in the first 12 months of the Framework Agreement the value of the purchases will be circa £20,000,000. For the full 36 month term (if extended) the anticipated value is circa £75,000,000. These values are approximate only and are based on the most recent historical usage information, with a forecasted level of growth. The values provided are for guidance only and are not a guarantee of business or volumes to be purchased from any Supplier.
CPV: Devices and instruments for transfusion and infusion · Industry specific software package · Infusion pumps · Infusion supplies
How this framework works
From the published notice- Places
- up to 18 suppliers · 2 bids received (0.1 per place) · 2 appointed
- Electronic auction
Although an electronic auction will not be used to award all or part of the requirements of the Framework Agreement the use of eAuctions may be an option as part of any contracts awarded under the Framework Agreement.
Lots and requirements (6)Procurement structure
6 lots · 3 with a published value · a supplier may bid for at most 3 and win at most 3 of them · same evaluation weights on every lotLot #1Insulin PumpsCancelledLot estimate not published
This lot is for Standalone Insulin Pumps and also Tethered Insulin Pumps, Patch Insulin Pumps, Tethered Pump with Integrated Continuous Glucose Monitor, Patch Pumps with Integrated Continuous Glucose Monitor, Tethered Pump with Integrated Continuous Glucose Monitor and Algorithm. This Lot also includes, but is not limited to;
Insulin subcutaneous infusion set
Tubes
Cannula’s
Needle cartridges
Handsets
Insertion Devices
Adaptors
Batteries
Carry Cases
Belts
Remotes
Sensors
Finger Prickers
Battery caps
Resevoirs
USB Adapters
Clips
Luer Locks
Dressings
Pouches
Service packs
Any other option or accessory used with or to configure the pumps. Additional information: Anticipated expenditure will be circa £9,000,000 for the two years of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement. For the full 36 month term (if extended) the anticipated value is circa £27,000,000. These values are approximate, based on historical usage information, with a forecasted level of growth.
Lot #2Continuous Glucose MonitorsCancelledLot estimate not published
This lot is for standalone CGM and Flash Glucose Monitoring. This Lot also includes Receivers, Transmitters, Sensors and Flash Glucose Monitoring Devices. This lot includes but is not limited to:
Handsets
Sensors
Carry cases
Tapes
Finger prickers
Clips
Dressings
Adhesives
Insertion devices
Testers
Service Packs
Download Features
Any other option or accessory used to configure the unit. Additional information: Anticipated expenditure will be circa £3,750,000 in the first year of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement.For the full 36 month term (if extended) the anticipated value is circa £10,875,000. These values are approximate, based on historical usage information, with a forecasted level of growth.
Lot #3Software and Diabetes Management SystemsCancelledLot estimate not published
This lot is for Applications, Software or Algorithms that contribute to the functionality of a Closed/Semi Closed Loop Insulin Delivery System and Diabetes Management Systems that allow for the uploading of information from Insulin Pumps, CGM’s, Glucose Meters and/or Mobile Applications.
Mobile applications that act only as an Insulin Pump or CGM controller must not be included in this lot and must instead be submitted as an accessory in the relevant lot where the Pump or CGM device sits. Additional information: Anticipated expenditure will be circa £3,000,000 for the two years of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement.For the full 36 month term (if extended) the anticipated value is circa £9,000,000. These values are approximate, based on historical usage information, with a forecasted level of growth.
Lot #4Insulin PumpsPublished value£9,000,000
This lot is for Standalone Insulin Pumps and also Tethered Insulin Pumps, Patch Insulin Pumps, Tethered Pump with Integrated Continuous Glucose Monitor, Patch Pumps with Integrated Continuous Glucose Monitor, Tethered Pump with Integrated Continuous Glucose Monitor and Algorithm. This Lot also includes, but is not limited to;
Insulin subcutaneous infusion set
Tubes
Cannula’s
Needle cartridges
Handsets
Insertion Devices
Adaptors
Batteries
Carry Cases
Belts
Remotes
Sensors
Finger Prickers
Battery caps
Resevoirs
USB Adapters
Clips
Luer Locks
Dressings
Pouches
Service packs
Any other option or accessory used with or to configure the pumps Additional information: Anticipated expenditure will be circa £9,000,000 for the first year of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement. For the full 36 month term (if extended) the anticipated value is circa £27,000,000. These values are approximate, based on historical usage information, with a forecasted level of growth.
Lot #5Continuous Glucose MonitorsPublished value£3,750,000
This lot is for standalone CGM and Flash Glucose Monitoring. This Lot also includes Receivers, Transmitters, Sensors and Flash Glucose Monitoring Devices. This lot includes but is not limited to:
Handsets
Sensors
Carry cases
Tapes
Finger prickers
Clips
Dressings
Adhesives
Insertion devices
Testers
Service Packs
Download Features
Any other option or accessory used to configure the unit Additional information: Anticipated expenditure will be circa £3,750,000 in the first year of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement. For the full 36 month term (if extended) the anticipated value is circa £11,250,000. These values are approximate, based on historical usage information, with a forecasted level of growth.
Lot #6Software and Diabetes Management SystemsPublished value£3,000,000
This lot is for Applications, Software or Algorithms that contribute to the functionality of a Closed/Semi Closed Loop Insulin Delivery System and Diabetes Management Systems that allow for the uploading of information from Insulin Pumps, CGM’s, Glucose Meters and/or Mobile Applications.
Mobile applications that act only as an Insulin Pump or CGM controller must not be included in this lot and must instead be submitted as an accessory in the relevant lot where the Pump or CGM device sits. Additional information: Anticipated expenditure will be circa £3,000,000 for the first year of this framework agreement, this is approximate and may vary depending on the requirements of bodies purchasing under the agreement. For the full 36 month term (if extended) the anticipated value is circa £9,000,000. These values are approximate, based on historical usage information, with a forecasted level of growth.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (3)
- Working with NHSSC: 30%
- Patient Experience: 35%
- Customer Support: 35%
Published award criteria (4)
- Working with NHSSC: 30
- Patient Experience: 35
- Customer Support: 35
- Price: 0
- Suitability
Applicants should refer to II.2 of this Contract Notice for further details in respect of appointment to the individual Lots across the Framework Agreement.
Applicants may bid for one, more than one or all of the Lots and Applicants should refer to the Invitation to Tender for more information in respect of this.
The term of contracts formed under the Framework Agreement may continue beyond the end of the term of the Framework Agreement itself.
NHS Supply Chain expects to provide successful Suppliers with the opportunity to offer additional savings to customers through the provision of discounted pricing, rebates, value added offerings, the application of price bandings, commitment initiatives, and any other savings offers Suppliers may put forward.
NHS Supply Chain will share savings information in order to assist its customers with making informed procurement decisions. 1) NHS Supply Chain; 2) any NHS Trust; 3) any other NHS entity; 4) any government department, agency or other statutory body (for the avoidance of doubt including local authorities) and/or 5) any private sector entity active in the UK healthcare sector will be able to directly order under the Framework Agreement and will be able to enter into a direct contract with the Applicant for any of the Goods under the Framework. Direct contracts placed under the Framework Agreement by parties other than NHS Supply Chain are between the party and the Applicant, NHS Supply Chain is not a party to those contracts.
…
- “Insulin Pumps, Continuous Glucose Monitoring, Closed Loop Insulin…” is a framework: the contest is a place on its panel, up to 18 suppliers, not a single contract.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 22 Jun 2022, 14:53 BST
- Last source update
- 20 Dec 2022, 09:42 GMT
- Award evaluation window
- 29 Sept 2022 – …
- FTS notice number
2022/S 000-035953- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03494cFind a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Performance terms
The Framework Agreement includes obligations with respect to environmental issues and a requirement for successful suppliers to comply with the NHS Supply Chain Code of Conduct.
- Review procedure
Appeals to be logged in accordance with the Public Contracts Regulations 2015 (as amended)
Publisher note: Submission of expression of interest and procurement specific information: This procurement exercise will be conducted on the NHS Supply Chain eProcurement portal at https://nhssupplychain.app.jaggaer.com/ Candidates wishing to be considered for this contract must register their expression of interest and provide additional procurement-specific information (if required) through the NHS Supply Chain eProcurement portal using the URL https://nhssupplychain.app.jaggaer.com/ to access the portal. Applicants are encouraged to download the supplier handbook located within the eProcurement portal by following the 'Supplier Helpcentre' link within the Useful Links section of the Dashboard. For any technical help with the portal please contact: Tel: 0800 069 8630 or email: [email protected] Please refer to Section III.1.1 for additional information.
How it was run
Official noticeTender documents are also served through a separate tool: https://nhssupplychain.app.jaggaer.com/ ↗
- Appointment period ends
- 28 Sept 2022, 15:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 210 days from the deadline
- Bids opened
- 29 Sept 2022, 09:00 BST
Timeline
26 Sept 2022 → 20 Dec 2022 · 4 dates- Next notice expected26 Sept 2022, 00:00 BST
- Admission / appointment period endsperiod end, not a bid countdown28 Sept 2022, 15:00 BST
- Bids opened29 Sept 2022, 09:00 BST
- Notice published20 Dec 2022, 09:42 GMT
Notice history
6 events · 3 releases on Find a Tender · since 31 Aug 2022- Published value updated to £75,000,00031 Aug 2022, 15:44 BSTwas £100,000,000
- Status changed to active31 Aug 2022, 15:44 BST
- Procurement method changed31 Aug 2022, 15:44 BST
- Deadline published: 28 Sept 2022, 15:00 BST31 Aug 2022, 15:44 BST
- Buyer details updated31 Aug 2022, 15:44 BST
- Status changed to complete20 Dec 2022, 09:42 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast2 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Insulin Pumps
- Signed
- 22 Nov 2022
- Value
- £9,000,000
- Status
- active
Continuous Glucose Monitors
- Signed
- 22 Nov 2022
- Value
- £3,750,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 2bids · 2 electronic · 2 from abroad | 2 | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeDispute resolution & review bodies
- Not ApplicableReview body
Process and specification contact points (1)
- DHL Supply Chain LimitedProcess contact point
Framework contractors & participating bidders
3 commercial parties on the notice- Roche Diabetes Care LimitedFramework contractor
- TLB Medical SuppliesFramework contractor
- TLB Medical Supplies LtdFramework contractor
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria